This session explores how molecular imaging and theranostic strategies redefine diagnosis and treatment across brain disorders, from neuropsychiatric conditions to oncologic care. Experts will present advances in mapping brain connectivity disruptions, targeted radioligand therapies for brain tumours, and PET-guided disease-modifying therapies in neurodegenerative disorders. Attendees will gain insights into translating these applications into clinical practice to improve patient outcomes.
Chairperson's introduction
Valentina Garibotto, Geneva / Switzerland
Molecular imaging of brain disconnectivity
Igor Yakushev, Munich / Germany
Towards theranostics in neuro-oncology
Nelleke Tolboom, Amsterdam / Netherlands
PET imaging in the era of Alzheimer's disease modifying drugs
Valentina Garibotto, Geneva / Switzerland
Panel discussion: How do we translate methodological advances into clinical practice?